EDIT
Editas Medicine·NASDAQ
--
--(--)
--
--(--)
EDIT fundamentals
Editas Medicine (EDIT) released its earnings on Nov 10, 2025: revenue was 7.54M (YoY +12265.57%), beat estimates; EPS was -0.28 (YoY +62.67%), beat estimates.
Revenue / YoY
7.54M
+12265.57%
EPS / YoY
-0.28
+62.67%
Report date
Nov 10, 2025
EPS
Actual | -0.69 | -0.43 | 0.12 | -1 | -0.86 | -0.81 | -0.57 | -0.61 | -0.74 | -0.78 | -0.81 | -0.88 | -0.71 | -0.56 | -0.55 | -0.23 | -0.76 | -0.82 | -0.75 | -0.55 | -0.92 | -0.63 | -0.28 | |||||||||
Forecast | -0.7871 | -0.7856 | -0.626 | -0.76 | -0.7438 | -0.8235 | -0.8129 | -0.7122 | -0.7817 | -0.8083 | -0.8529 | -0.7886 | -0.7841 | -0.7669 | -0.5751 | -0.594 | -0.6256 | -0.704 | -0.747 | -0.3774 | -0.564 | -0.3906 | -0.2961 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +12.34% | +45.26% | +119.17% | -31.58% | -15.62% | +1.64% | +29.88% | +14.35% | +5.33% | +3.50% | +5.03% | -11.59% | +9.45% | +26.98% | +4.36% | +61.28% | -21.48% | -16.48% | -0.40% | -45.73% | -63.12% | -61.29% | +5.44% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.72M | 10.75M | 62.84M | 11.42M | 6.50M | 379.00K | 6.20M | 12.47M | 6.77M | 6.40M | 42.00K | 6.54M | 9.85M | 2.89M | 5.34M | 60.05M | 1.14M | 513.00K | 61.00K | 30.60M | 4.66M | 3.58M | 7.54M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.72M | 6.34M | 6.36M | 5.64M | 5.83M | 6.03M | 4.74M | 4.64M | 3.85M | 4.29M | 4.39M | 3.66M | 3.29M | 4.17M | 3.70M | 3.70M | 11.14M | 4.78M | 3.93M | 29.76M | 641.91K | 2.31M | 4.94M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -14.90% | +69.66% | +888.51% | +102.36% | +11.57% | -93.71% | +30.78% | +168.51% | +75.76% | +49.16% | -99.04% | +78.68% | +199.87% | -30.80% | +44.08% | +1523.91% | -89.81% | -89.27% | -98.45% | +2.85% | +625.65% | +55.21% | +52.61% |
Earnings Call
You can ask Aime
What is Editas Medicine's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Editas Medicine year over year?What is the market's earnings forecast for Editas Medicine next quarter?What were the key takeaways from Editas Medicine's earnings call?What factors drove the changes in Editas Medicine's revenue and profit?What guidance did Editas Medicine's management provide for the next earnings period?What does Editas Medicine do and what are its main business segments?Did Editas Medicine beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
